Recurring concern
Failure to identify clinically significant medication risks
First reported 30 Jul 2013•Latest report 3 Jun 2026
What this concern includes
Includes failures in medication review, reconciliation, prescribing or screening that concern recognising the clinical significance of a medicine, contraindication, interaction, toxicity, side-effect or existing medication.
Not included
- Excludes failures to administer, monitor or supply medication where the concern is not specifically the identification of medication-related risk.
- Excludes illicit or general drug-use hazards not tied to a medication-safety control.
- Excludes generic failures to recognise symptoms or deterioration unless the report explicitly links them to medication-related risk.
- Excludes generic communication, documentation or staffing deficiencies that are not dedicated to identifying medication risks.
- Reports
- 54
- Individual concerns
- 58
- Date range
- 2013–2026
- Stated actions
- 100
Distinct published reports
A report can raise multiple concerns
First to latest report issue date
Described in published responses
Reports over time
Reports over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Concerns and responses across reports
Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.
-
Concerns raised1
Lack of prescriber awareness of Gabapentin's rare side effect of precipitating diabetic coma
This report raised 1 other concern. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
Actions described in response An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.1
-
Action
Build the drug-safety review into day-to-day clinical practice.
Stated by Guy'S and St Thomas' NHS Foundation Trust
-
Concerns raised1
Failure to withhold insulin when blood sugars are dangerously low
This report raised 1 other concern. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
-
Concerns raised1
Failure to account for self-harm and suicidal tendencies when supplying unsupervised medication
This report raised 4 other concerns. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
-
Concerns raised1
Delays in discontinuing Tramadol after onset of confusion
This report raised 4 other concerns. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
Data last updated 7 September 2026